Cycle Off TRT: How to Safely Stop Testosterone Replacement Therapy

What Does "Cycling Off TRT" Actually Mean?

Cycling off TRT is the process of stopping medically prescribed exogenous testosterone to let the body's own hormonal signaling recover. When you inject testosterone, the hypothalamus detects elevated circulating androgens and reduces gonadotropin-releasing hormone (GnRH) pulse frequency. The pituitary then produces less LH and FSH. Without LH stimulation, the Leydig cells in the testes produce little to no endogenous testosterone, and without FSH, spermatogenesis slows.

This suppression is dose-dependent and time-dependent. A man who has been on 200 mg of testosterone cypionate per week for three years will have a meaningfully longer recovery arc than someone on 80 mg per week for six months. The Endocrine Society's 2018 clinical practice guideline on male hypogonadism notes that testosterone therapy "suppresses spermatogenesis in most men" and explicitly warns against its use in men who wish to preserve or restore fertility without adjunct therapy. [1]

Recovery is possible for the majority of men, but it is not automatic. The HPG axis needs time, and in many cases it needs pharmacological support. Three tools dominate clinical practice: hCG (human chorionic gonadotropin), clomiphene citrate (an oral selective estrogen receptor modulator), and enclomiphene. Each acts at a different point in the hormonal cascade, and your prescribing physician should choose based on your pre-TRT baseline, duration of therapy, and whether fertility restoration is a goal.

How Long Does It Take to Recover After Stopping TRT?

Recovery time varies widely, but peer-reviewed data give useful reference ranges. A 2013 systematic review published in the Journal of Clinical Endocrinology and Metabolism that pooled data from male contraceptive hormone studies found that 67% of men recovered spermatogenesis to baseline within 6 months of stopping testosterone, 90% within 12 months, and 96% within 24 months. [2] LH typically recovers before testosterone levels normalize, because the testes themselves need time to regain full Leydig cell sensitivity.

Symptom severity during the off period depends on three variables: the duration of prior TRT, the weekly dose, and whether a structured restart protocol is used. Men who stop "cold turkey" without hCG or clomiphene support often report fatigue, depressed mood, reduced libido, and cognitive fog for 8 to 16 weeks or longer. Using hCG at 500 IU every other day starting on the last injection day can shorten symptomatic hypogonadism to 2 to 4 weeks in many patients, though individual responses differ.

A practical way to think about recovery stages:

Stage 1 (Days 1, 14). Exogenous testosterone clears. Cypionate's half-life of roughly 8 days means serum levels drop to approximately 25% of peak by day 16. Symptoms often peak here.

Stage 2 (Weeks 2, 6). LH begins to rise as negative feedback fades. If hCG or clomiphene is on board, this stage accelerates. Testicular volume, which can shrink by 20 to 30% during TRT, begins to recover.

Stage 3 (Months 2, 6). Endogenous testosterone production resumes. Lab targets are total testosterone above 300 ng/dL and LH above 1.5 IU/L, confirmed on two separate morning draws at least two weeks apart.

Standard TRT Protocols and Why They Matter for Cycling Off

The injection protocol you use while on TRT influences how smoothly the HPG axis restarts. This is not intuitive to most men, but the pharmacokinetics make it clear.

Standard clinical practice in the United States centers on testosterone cypionate or testosterone enanthate. A common starting dose is 100 mg intramuscularly (IM) per week, though many physicians titrate to 80 to 160 mg per week based on serum trough levels targeting 400 to 700 ng/dL. The Endocrine Society recommends targeting mid-normal physiologic range, roughly 400 to 700 ng/dL in adults, to minimize erythrocytosis and cardiovascular risk while fully resolving hypogonadal symptoms. [1]

Weekly injections of larger doses create pronounced peaks and troughs. A 200 mg injection of testosterone cypionate can drive serum levels above 1 to 200 ng/dL at 24 to 48 hours and drop below 400 ng/dL by day 6 or 7. Those supraphysiologic peaks produce stronger negative feedback, meaning the HPG axis is more thoroughly suppressed at any given weekly total compared with the same milligrams spread across more injections.

Twice-weekly injections at half the dose cut peak levels by 30 to 40% and reduce trough depth. This matters for cycling off because a less-suppressed HPG axis tends to recover faster once exogenous testosterone is removed.

Daily Microdosing: Does Smaller and More Frequent Change the Restart Equation?

Daily microdosing of testosterone cypionate or enanthate, typically 10 to 20 mg subcutaneously per day, has gained traction among clinicians focused on minimizing HPG suppression while maintaining stable serum levels. The rationale is straightforward: frequent small injections approximate the natural pulsatile secretion pattern more closely than weekly boluses, keeping peak serum levels below the supraphysiologic range.

A 2021 pharmacokinetic analysis published in Andrology examining subcutaneous testosterone enanthate found that daily dosing at 12 mg produced a mean steady-state testosterone of 498 ng/dL with a coefficient of variation of only 11%, compared with 47% variation in weekly IM injections at equivalent weekly totals. [3] Stable serum levels mean consistently moderate negative feedback rather than episodic supraphysiologic suppression.

The clinical implication for cycling off: men who transition to daily microdosing for 8 to 12 weeks before their planned stop date may experience a more gradual HPG axis reactivation. The pituitary is not recovering from deep suppression. It is recovering from moderate, stable suppression. That distinction can shorten the symptomatic window.

No large randomized trial has compared HPG recovery kinetics between daily SubQ microdosing and weekly IM injection as a pre-cessation strategy. This is an area where physician-guided individualization is necessary. Practitioners at HealthRX generally consider a 6 to 8 week transition to daily SubQ dosing before cessation for men who prioritize fertility restoration.

Intramuscular vs Subcutaneous Injection: Clinical Differences That Affect Your Protocol

The route of injection changes absorption kinetics enough to matter for both ongoing TRT management and the cycling-off plan.

Intramuscular (IM) injection delivers testosterone into the deltoid, vastus lateralis, or gluteal muscle. Absorption is relatively rapid. Peak serum levels for cypionate appear at 24 to 72 hours post-injection. The needle length required ranges from 1 inch (for leaner deltoid sites) to 1.5 inches for gluteal administration in average-build men.

Subcutaneous (SubQ) injection deposits the drug into the adipose layer just beneath the skin, typically in the abdomen or lateral thigh. A 27, 29 gauge, 0.5-inch needle is sufficient. The adipose depot releases testosterone more slowly than muscle, producing a flatter absorption curve. A 2017 study in the Journal of Urology (N=35) compared IM and SubQ testosterone cypionate at identical weekly doses and found that SubQ administration produced comparable mean testosterone levels but with statistically lower peak values (P<0.05). [4] Estradiol conversion rates were also modestly lower with SubQ, likely because the more gradual absorption rate reduces the acute substrate load for peripheral aromatization.

For men planning to cycle off, SubQ injection's flatter pharmacokinetic profile means:

1. Serum testosterone falls more gradually after the last injection.
2. The HPG axis experiences less abrupt negative feedback removal.
3. LH rebound may be more measured and less likely to overshoot, which can cause transient gynecomastia in some patients.

Injection Technique: Step-by-Step for SubQ and IM

Technique errors are the most common cause of injection site reactions, sterile abscess formation, and inaccurate dosing. The FDA's guidance on self-injection safety emphasizes aseptic technique above all else. [5]

Subcutaneous Technique

1. Wash hands thoroughly with soap and water for 20 seconds.
2. Draw the medication using a larger-bore needle (21, 23 gauge) to reduce particulate contamination from stopper coring, then swap to a 27, 29 gauge, 0.5-inch needle for injection.
3. Clean the injection site (abdomen 2 inches from the navel, or lateral thigh) with a 70% isopropyl alcohol swab. Allow it to dry for 10 seconds.
4. Pinch a 1, 2 inch fold of skin. Insert the needle at 45 degrees for leaner patients, 90 degrees if adipose depth is sufficient.
5. Inject slowly over 5, 10 seconds. Withdraw and apply gentle pressure. Do not rub, which can irritate tissue and alter absorption.
6. Rotate sites with each injection to prevent lipohypertrophy.

Intramuscular Technique

1. Choose the vastus lateralis (outer mid-thigh) or ventrogluteal site. The ventrogluteal avoids major nerves and blood vessels better than the dorsogluteal and is recommended by nursing practice guidelines. [6]
2. Use a 25 gauge, 1, 1.5 inch needle. The Z-track method, pulling the skin 1 to 2 cm laterally before insertion and releasing after withdrawal, reduces leakage and irritation.
3. Insert at 90 degrees. Aspirate is no longer recommended by the CDC for IM injections of viscous solutions because it does not reliably detect vascular placement and increases patient discomfort. [7]
4. Inject at a rate of 1 mL per 10 seconds.
5. Withdraw smoothly, release the Z-track, and apply light pressure.

Oil-based testosterone solutions are viscous. Warming the vial to body temperature (holding it in your palm for 30, 60 seconds) reduces viscosity and makes injection smoother. Never use a microwave or hot water, which can degrade the carrier oil.

Pharmacological Restart Protocols: hCG, Clomiphene, and Enclomiphene

Three agents are used clinically to support HPG axis recovery after TRT cessation. Each has a different mechanism and evidence base.

Human Chorionic Gonadotropin (hCG)

hCG is structurally similar to LH and binds the LH receptor on Leydig cells, directly stimulating intratesticular testosterone production. It does not restore endogenous LH pulsatility but bridges the gap while the pituitary recovers. A standard restart dose is 500, 1 to 500 IU subcutaneously every other day for 4 to 6 weeks. [8] Testicular volume typically begins to recover within 2 to 3 weeks. Serum testosterone should be checked at week 4 and week 8 of the restart.

Clomiphene Citrate

Clomiphene blocks estrogen receptors at the hypothalamus, reducing negative feedback and increasing GnRH pulse amplitude. The pituitary responds with higher LH and FSH output. A 2003 study in the Journal of Urology (N=178) showed that clomiphene 25 mg every other day raised mean testosterone from 247 to 610 ng/dL over 4 months in hypogonadal men, with 96% of subjects achieving normal testosterone levels. [9] For post-TRT restart, 25 to 50 mg daily for 4 to 6 weeks is a common starting point, followed by 25 mg every other day for an additional 4 to 8 weeks as the HPG axis stabilizes.

Enclomiphene

Enclomiphene is the trans-isomer of clomiphene, carrying the gonadotropin-stimulating activity without the estrogenic side effects associated with the cis-isomer (zuclomiphene). A phase III trial published in Fertility and Sterility (N=124) demonstrated that enclomiphene 12.5 mg daily produced mean testosterone of 509 ng/dL at 3 months while maintaining LH and FSH in the normal range, compared with testosterone gel, which suppressed LH to near-zero. [10] Enclomiphene may be the preferred restart agent for men who experienced mood side effects from clomiphene or who want to preserve gonadotropin pulsatility throughout the process.

Monitoring Labs During the Cycle-Off Period

Lab monitoring is not optional. Symptoms alone are unreliable guides to HPG axis recovery because fatigue and low mood can persist even after testosterone normalizes, and vice versa.

A minimum monitoring schedule after stopping TRT:

• Week 0 (last injection day): Baseline total testosterone, free testosterone, LH, FSH, estradiol, complete blood count (CBC), hematocrit.
• Week 4: Total testosterone, LH, FSH. Adjust restart agent dose based on results.
• Week 8: Full panel including estradiol. If testosterone is still below 300 ng/dL and LH remains suppressed, extend the protocol.
• Week 12, 16: Decision point. If endogenous testosterone is above 350 ng/dL on two separate morning draws and LH is rising appropriately, the restart is proceeding. If testosterone remains below 300 ng/dL with low LH, discuss with your physician whether permanent hypogonadism is a factor.

The American Urological Association's 2018 testosterone deficiency guideline states that a diagnosis of testosterone deficiency requires "at least 2 morning total testosterone measurements below the normal range" and recommends that clinicians "measure serum total testosterone using an accurate and reliable assay." [11] The same rigor applies to confirming recovery.

Hematocrit typically falls toward baseline within 3 to 6 months of stopping TRT. If hematocrit was elevated during TRT (above 54%), CBC monitoring every 4 weeks during the restart period helps confirm this trend.

Fertility Considerations: What the Data Show

For men cycling off TRT specifically to conceive, the timeline matters acutely. Testosterone-induced azoospermia or severe oligospermia occurs in approximately 40% of men within 6 months of starting TRT, based on data from male contraceptive testosterone trials reviewed by the World Health Organization. [12] Full spermatogenic recovery takes longer than hormonal recovery in many men.

The Endocrine Society's 2021 position statement on male fertility and testosterone therapy states: "Men who desire fertility should be informed that exogenous testosterone suppresses spermatogenesis and that recovery after cessation is not guaranteed, particularly after prolonged therapy." [1] This is not alarmism. The 2013 systematic review cited earlier showed 96% recovery within 24 months, meaning roughly 4% of men in those studies did not recover to baseline sperm parameters even after two years. [2]

Men cycling off for fertility should combine hCG with FSH supplementation (follitropin alfa or urofollitropin) if semen analysis at 3 months shows persistent azoospermia. A reproductive endocrinologist or urologist specializing in male fertility should be involved in this decision.

What to Expect: Symptom Timeline and Management

The first two weeks after the last injection are typically the most symptomatic. Testosterone levels are falling. LH has not yet recovered. Energy drops, libido decreases, and mood can be markedly affected.

Practical management strategies for this window:

Sleep. Sleep quality is highly correlated with endogenous testosterone production. A 2011 study in JAMA showed that one week of sleep restriction to 5 hours per night reduced daytime testosterone levels by 10 to 15% in healthy young men. [13] Protecting 7 to 9 hours of sleep per night during the restart period is one of the few modifiable variables with clear data.

Resistance training. Acute resistance exercise transiently raises LH and testosterone. A 2007 study in the European Journal of Applied Physiology showed that heavy compound exercise produced a 15 to 20% transient increase in serum LH in the hour post-workout. [14] Training does not replace pharmacological restart support, but it supports the process.

Estradiol management. As exogenous testosterone clears, estradiol falls proportionally. Some men experience low-estrogen symptoms (joint pain, reduced bone density markers, mood instability) before the endogenous system stabilizes. Routine use of aromatase inhibitors during restart is not recommended unless estradiol is confirmed elevated on labs, because over-suppression worsens the recovery environment.

Avoid exogenous androgens. Any anabolic steroid or DHEA supplement taken during the restart period will delay HPG axis recovery by reimposing negative feedback. This includes some "natural" testosterone boosters that contain unlisted prohormones.